r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

JS

Jeffrey Lawrence Schwartz

Insider · Director and 10% owner · KMTS

Jeffrey Lawrence Schwartz files insider transactions with the SEC as a director and 10% owner of Kestra Medical Technologies. We hold 1 disclosed purchase or sale filed since 16 September 2019, 1 of them in the last 90 days.

  • Files for 4 companiesKMTS, RPID, SWTX, BLSA
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure10 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 4 September 2025 — 9 September 2026Director and 10% owner · Kestra Medical Technologies 3 Form 4 lines · source: SEC Form 4
  • Filed 14 July 2021 — 23 May 2024Director and 10% owner · Rapid Micro Biosystems 5 Form 4 lines · source: SEC Form 4
  • Filed 29 March 2019 — 24 May 2023Director · SpringWorks Therapeutics 11 Form 4 lines · source: SEC Form 4
  • Filed 26 October 2020 — 26 October 2020Chief Executive Officer · BCLS Acquisition 1 Form 4 line · source: SEC Form 4

Every transaction

20 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
20 of 20 shown
9 Sep 202610 Sep 2026SEC Form 41 dwas grantednot a tradeKestra Medical Technologies7,217 sharesdown −5.1%down −3.1%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketKestra Medical Technologies3,890 sharesdown −10.9%down −3.1%
4 Sep 20258 Sep 2025SEC Form 44 dwas grantednot a tradeKestra Medical Technologies10,909 sharesup +38.4%up +27.9%
23 May 202428 May 2024SEC Form 45 dwas grantednot a tradeRapid Micro Biosystemsderivative28,650 sharesup +50.0%up +53.4%
23 May 202428 May 2024SEC Form 45 dwas grantednot a tradeRapid Micro Biosystems14,300 sharesup +50.0%up +53.4%
24 May 202325 May 2023SEC Form 41 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative13,774 shares——
24 May 202325 May 2023SEC Form 41 dwas grantednot a tradeSWTXSpringWorks Therapeutics4,648 shares——
4 May 20235 May 2023SEC Form 41 dwas grantednot a tradeRapid Micro Biosystemsderivative25,000 sharesup +41.2%up +38.2%
16 Mar 202320 Mar 2023SEC Form 44 dsold on the open marketSWTXSpringWorks Therapeutics1,750,000 shares——
23 May 202210 Jun 2022SEC Form 418 dwas grantednot a tradeRapid Micro Biosystemsderivative12,500 sharesdown −72.7%down −67.2%
19 May 202220 May 2022SEC Form 41 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative15,318 shares——
19 May 202220 May 2022SEC Form 41 dwas grantednot a tradeSWTXSpringWorks Therapeutics4,818 shares——
14 Jul 202116 Jul 2021SEC Form 42 dwas grantednot a tradeRapid Micro Biosystemsderivative25,000 shares—down −94.9%
20 May 202124 May 2021SEC Form 44 dwas grantednot a tradeSWTXSpringWorks Therapeutics1,106 shares——
20 May 202124 May 2021SEC Form 44 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative6,998 shares——
26 Oct 202026 Oct 2020SEC Form 40 dwas grantednot a tradeBLSABCLS Acquisition487,500 shares——
20 May 202022 May 2020SEC Form 42 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative7,464 shares——
12 Sep 201916 Sep 2019SEC Form 44 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative29,983 shares——
29 Mar 201916 Sep 2019SEC Form 4171 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative40,000,000 shares——
29 Mar 201916 Sep 2019SEC Form 4171 dwas grantednot a tradeSWTXSpringWorks Therapeuticsderivative6,931,142 shares——

Both percentages are the stock’s move, not Jeffrey Lawrence Schwartz’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 7 of the 20 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.